Might apixaban be the optimal oral anticoagulant for haemophiliacs with atrial fibrillation?
Department of Haematology, Hospital General Santa Bárbara, Soria, Spain.
C
C
Aguilar
D000284:Administration, Oral; D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy*; D005164:Factor IX / Q000032:analysis; D005169:Factor VIII / Q000032:analysis; D006467:Hemophilia A / Q000150:complications*; D006801:Humans; D011720:Pyrazoles / Q000627:therapeutic use*; D011728:Pyridones / Q000627:therapeutic use*
D000925:Anticoagulants; D011720:Pyrazoles; D011728:Pyridones; C522181:apixaban; D005169:Factor VIII; D005164:Factor IX